Intellipharmaceutics International Inc. (IPCI)

[numbersarefun]

Purdue versus IntelliPharmaCeutics Litigation Document link. IPCI's PR about the lawsuit did not contain an patent numbers. So here they are:

Purdue suing IPCI for 6 patents out of 16, while Purdue is suing Amneal for 3 patents. There are 2 patents which were granted a couple of weeks before IPCI filed Rexista NDA. There is 1 patent which was granted after IPCI filed NDA.

1) 8,309,060 - '060 ABUSE-PROOFED DOSAGE FORM, issued on November 13, 2012

2) 9,060,976 - '976 PHARMACEUTICAL FORMULATION CONTAINING GELLING AGENT, issued on June 23, 2015

3) 9,073,933 - '933 OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM
14-HYDROXYCODEINONE, issued on July 7, 2015

4) 9,492,389 - '389 TAMPER RESISTANT DOSAGE FORMS, issued on November 15, 2016

5) 9,492,391 - '391 TAMPER RESISTANT DOSAGE FORMS, issued on November 15, 2016

6) 9,522,919 - ’919 OXYCODONE COMPOSITIONS, issued on December 20, 2016


Purdue versus IntelliPharmaCeutics
Case 1:17-cv-00392-UNA Filed 04/07/17
https://search.rpxcorp.com/litigation_documents/12406652

--------------------------------------------

Purdue versus Amneal
Case 1:17-cv-00210-UNA Document 1 Filed 03/01/17
https://search.rpxcorp.com/litigation_documents/12356895

1) 9,492,392 - '392 TAMPER RESISTANT DOSAGE FORMS, issued on November 15, 2016

2) 9,492,393 - '393 TAMPER RESISTANT DOSAGE FORMS, issued on November 15, 2016

3) 9,522,919 - '919 OXYCODONE COMPOSITIONS, issued on December 20, 2016